JITM is an Open Access (OA) journal in English, all the manuscripts published can be read, downloaded or cited for free, the manuscripts you submit can be found rapidly and freely at any time all over the world, it means that if only your manuscripts are full of new useful information, they will be cited frequently. Since its first issue in March 2013, it has been indexed by Ulrich’s Periodicals Directory (UPD), Wanfang Data, Directory of Open Access Journals (DOAJ), Excerpta Medica (EMBASE), China Open Access Journals (COAJ), and Thomson Reuters’ Emerging Sources Citation Index (ESCI). We reached this milestone thanks to all of you and the numerous ways you support JITM.
ESCI is a new edition of Thomson Reuters’ Web of Science. Content in this index is under consideration to be accepted in the Science Citation Index Expanded (SCIE), which is an important step toward Science Citation Index (SCI) to obtain an impact factor. It has high requirements for all manuscripts to sets it apart from other research databases, and also is a testament to the quality of the Journal, and an indicator of what is to come.
JITM editors, members of the editorial board and peer reviewers, are professors from multiple areas realted to translational medicine all over the world, and the invited manuscripts from any corner of the world are in areas of translational medicine, including basic research, clinical research, brief report, investigation, case report and review.
We earnestly invite you to be one of the editorial board members of the JITM to cooperate with us. Please visit the website of JITM and e-mail us if you are interested in JITM. It will be better if you are working on translational medicine. In addition, we will be very thankful for your exciting research findings and review articles for publication in JITM by e-mail, and will offer a certain reward for the excellent manuscripts, and if you are willing to recommend some good manuscripts, we will also offer a certain reward for you, looking forward to your participation.
Warmly welcome contributions from the authors all over the world:
1. Preferentially publishing innovative, practical and original research findings in the field of translational medicine.
2. Novel insights, clear arguments, real and accurate data, standard statistics process and high academic value are required in your articles.
3. This journal adopts a fair anonymous reviewing system for each manuscript, and international editorial board members put forward professional opinions for your manuscripts.
4. The Article Publication Charge is waived for accepted manuscripts submitted from 2020-2022. Peer-review, proofreading and publication will be finished as soon as possible.
As authors, you will embrace the new global open access journal, promising good prospect for your manuscripts. As peer-reviewers, you will company and witness the significant development moments of JITM. As readers, you have read, learned, shared, and cited our high-quality articles and videos.